7:1034-1043 (2022) Acknowledgements This study was financially supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) (RS-2025-02218354) and by the R&D Program of MOTIE/KEIT (RS-2025-02307907)
One GLP-1RA, liraglutide, has been approved to treat obesity, and another, semaglutide, is in clinical trials
The choice of procedure depends on individual patient needs, comorbidities, and surgical goals
MDL, Class Action, or Mass Tort Coordination: Given the scale of GLP-1 litigation, your attorney may evaluate whether to file your case as part of an existing MDL proceeding or another coordinated legal action
Still, caution is required because the adoption of general medical treatments into psychiatry (for example, insulin therapy) has sometimes led to deleterious consequences for patients
In This Article [show] What GLP-1s Do to Bone: The Hansen Trial The most rigorous bone-specific data on GLP-1 therapy comes from Hansen et al